Brussels, 10/07/2014 (Agence Europe) - This is because synthetic marijuana leads to a state of inebriation, ranging from euphoria to hallucinations, but does not bring any beneficial effects to human health. Subsequently, it cannot be considered as a medicinal product, ruled the European Court of Justice in two related cases (C-358/13 and C-181/14) on Thursday 10 July.
European judges have therefore followed the opinion of the Advocate General presented in June 2014 (see EUROPE 11100). On...